S
S. Abdel-Rahman
Researcher at Ludwig Maximilian University of Munich
Publications - 45
Citations - 1781
S. Abdel-Rahman is an academic researcher from Ludwig Maximilian University of Munich. The author has contributed to research in topics: Ifosfamide & Soft tissue sarcoma. The author has an hindex of 16, co-authored 43 publications receiving 1466 citations.
Papers
More filters
Journal ArticleDOI
Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study
Rolf D. Issels,Lars H. Lindner,Jaap Verweij,Peter Wust,Peter Reichardt,Baard-Christian Schem,S. Abdel-Rahman,Soeren Daugaard,Christoph Salat,Clemens-Martin Wendtner,Zeljko Vujaskovic,Rüdiger Wessalowski,Karl-Walter Jauch,Hans Roland Dürr,Ferdinand Ploner,Andrea Baur-Melnyk,Ulrich Mansmann,Wolfgang Hiddemann,Jean-Yves Blay,Peter Hohenberger +19 more
TL;DR: This first randomised phase 3 trial to show that regional hyperthermia increases the benefit of chemotherapy is a new effective treatment strategy for patients with high-risk STS, including STS with an abdominal or retroperitoneal location.
Journal ArticleDOI
Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma: The EORTC 62961-ESHO 95 Randomized Clinical Trial
Rolf D. Issels,Lars H. Lindner,Jaap Verweij,Rüdiger Wessalowski,Peter Reichardt,Peter Wust,Pirus Ghadjar,Peter Hohenberger,Martin K. Angele,Christoph Salat,Zeljko Vujaskovic,Soeren Daugaard,Olav Mella,Ulrich Mansmann,Hans Roland Dürr,Thomas Knösel,S. Abdel-Rahman,Michael Schmidt,Wolfgang Hiddemann,Karl-Walter Jauch,Claus Belka,Alessandro Gronchi +21 more
TL;DR: Among patients with localized high-risk soft tissue sarcoma the addition of regional hyperthermia to neoadjuvant chemotherapy resulted in increased survival, as well as local progression-free survival.
Journal ArticleDOI
Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recurrent high-risk adult soft-tissue sarcomas (STS) of adults: long-term results of a phase II study.
Rolf-Dieter Issels,S. Abdel-Rahman,Clemens-Martin Wendtner,M.H. Falk,V Kurze,Hansjorg Sauer,U Aydemir,Wolfgang Hiddemann +7 more
TL;DR: In this phase II study, activity and safety of neoadjuvant regional hyperthermia (RHT) combined with chemotherapy was investigated in 59 patients with primary advanced or recurrent high-risk soft-tissue sarcoma and 36 patients were rendered disease-free.
Journal ArticleDOI
Response to Neoadjuvant Chemotherapy Combined With Regional Hyperthermia Predicts Long-Term Survival for Adult Patients With Retroperitoneal and Visceral High-Risk Soft Tissue Sarcomas
Clemens-M. Wendtner,S. Abdel-Rahman,Matthäus Krych,Jens Baumert,Lars H. Lindner,Andrea Baur,Wolfgang Hiddemann,Rolf D. Issels +7 more
TL;DR: Responsibility to neoadjuvant chemotherapy combined with RHT is predictive for an improved local tumor control resulting in a long-term survival benefit for patients with HR-STS at unfavorable RP/V sites; however, the impact of RHT has to be defined in a randomized phase III trial.
Journal ArticleDOI
Quality assurance for clinical studies in regional deep hyperthermia.
G. Bruggmoser,Stefan Bauchowitz,R A M Canters,Hans Crezee,Michael Ehmann,Johanna Gellermann,Ulf Lamprecht,Nicoletta Lomax,Marc Benjamin Messmer,Oliver J. Ott,S. Abdel-Rahman,Rolf Sauer,Manfred Schmidt,Andreas R. Thomsen,Rüdiger Wessalowski,Gerard C. van Rhoon +15 more
TL;DR: A guideline is provided for the implementation of regional deep hyperthermia treatments under strict rules of quality assurance to guarantee a comparable and comprehensible method in the treatment and scientific analysis ofhyperthermia.